SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001213900-21-068116
Filing Date
2021-12-30
Accepted
2021-12-30 16:05:38
Documents
2
Group Members
YAT-GAI AU

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13D ea153242-13da2regen_regen.htm SC 13D/A 55809
2 JOINT FILING AGREEMENT, DATED DECEMBER 30, 2021 ea153242ex7-1_regen.htm EX-7.1 3636
  Complete submission text file 0001213900-21-068116.txt   61108
Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell Bioscience Holdings Ltd (Subject) CIK: 0001829667 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A | Act: 34 | File No.: 005-92718 | Film No.: 211532893
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077
Business Address 11/F FIRST COMMERCIAL BUILDING 33-35 LEIGHTON ROAD, CAUSEWAY BAY HONG KONG K3 999077 852 2155 0823
Regencell (BVI) Ltd (Filed by) CIK: 0001874958 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: SC 13D/A